Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2
As key negative regulator of the p53 tumour suppressor, Mdm2 is an attractive therapeutic target. Small molecules such as Nutlin have been developed to antagonise Mdm2, resulting in p53-dependent death of tumour cells. We have recently described a mutation in Mdm2 (M62A), which precludes binding of...
Saved in:
Main Authors: | Chee, Sharon Min Qi, Wongsantichon, Jantana, Soo Tng, Quah, Robinson, Robert, Joseph, Thomas L., Verma, Chandra, Lane, David P., Brown, Christopher J., Ghadessy, Farid J. |
---|---|
Other Authors: | Maki, Carl G. |
Format: | Article |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/105057 http://hdl.handle.net/10220/20419 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2
by: Chee S.M.Q., et al.
Published: (2019) -
Inhibition of Nutlin-resistant HDM2 mutants by stapled peptides
by: Wei, S.J., et al.
Published: (2014) -
Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids
by: Chee S.M.Q., et al.
Published: (2019) -
Mechanism of stapled peptide binding to MDM2 : possible consequences for peptide design
by: Sim, Adelene Y. L., et al.
Published: (2015) -
Mechanism of stapled peptide binding to MDM2: Possible consequences for peptide design
by: Sim, A.Y.L., et al.
Published: (2014)